Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: Glucose impairs tamoxifen sensitivity modulating CTGF in breast cancer cells

PROVIDER: PRJNA382560 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5443647_1.fastq.gz	Fastqsanger.gz
	SRR5443647_2.fastq.gz	Fastqsanger.gz
	SRR5443648_1.fastq.gz	Fastqsanger.gz
	SRR5443648_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Glucose impairs tamoxifen sensitivity modulating CTGF in breast cancer cells

Project description:Metabolic diseases, including type 2 diabetes and obesity are relevant negative prognostic factor in patients with breast cancer (BC). We have investigated the mechanisms through which elevated glucose levels affect tamoxifen sensitivity of estrogen receptor positive (ER+) BC cells. We found that MCF7 BC cell sensitivity to tamoxifen was 2-fold reduced in 25mM glucose (HG), a concentration mimicking hyperglycaemia, compared to 5.5 mM glucose (LG), resembling normal fasting glucose levels in humans. Shifting MCF7 cells from HG to LG ameliorated their responsiveness to tamoxifen. RNA-Sequencing revealed that glucose modified the transcriptome of MCF7 cells. In particular, cell cycle-related genes were affected by glucose. Combining gene specific knockdown and treatment with human recombinant proteins, we identified the Connective Tissue Growth Factor (CTGF) as glucose-induced factor able to reduce MCF7 cell sensitivity to tamoxifen. Moreover, we found that both CTGF expression levels and tamoxifen responsiveness were enhanced co-culturing MCF7 cells with human adipocytes through an Interleukin-8 (IL8)-mediated mechanism. Indeed, IL8 inhibition reduced CTGF levels and rescued tamoxifen sensitivity in MCF7 cells. Interestingly, CTGF immuno-detection in bioptic specimens obtained from women with ER+ BC correlated with distant metastases (P-value = 0.000), hormone therapy resistance (P-value = 0.000), reduced overall (P-value = 0.051) and disease free survival (P-value = 0.000). Thus, glucose affects tamoxifen responsiveness directly modulating CTGF in BC cells, and indirectly promoting the adipocytes’ release of IL8. Both CTGF and IL8 may represent potential targets in novel therapeutic strategies to increase tamoxifen sensitivity.

2017-07-01 | GSE97647 | GEO

Homo sapiens Raw sequence reads-ferroptosis resistance

Project description:To study pathways associated with ferroptosis sensitivity

2022-06-01 | GSE173905 | GEO

Homo sapiens

Project description:Cold atmospheric plasma reprograms the drug sensitivity of Tamoxifen-resistant MCF-7 breast cancer cell

| PRJNA376413 | ENA

Homo sapiens

Project description:Tamoxifen-resistant human breast cancer cell lines

| PRJNA111659 | ENA

Homo sapiens

Project description:Tamoxifen and Palbociclib Resistance in Breast Cancer